We are writing to commend the recent article by Song et al., titled "IGF2BP3 promotes the proliferation and cisplatin resistance of bladder cancer by enhancing the mRNA stability of CDK6 in an m6A dependent manner1," published in the International Journal of Biological Sciences. This evidence concerns the gene IGF2BP3 and urinary bladder carcinoma.